Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells
Authors Geng Y, Liu J, Xie Y, Jiang H, Zuo K, Li T, Liu Z
Received 5 March 2018
Accepted for publication 16 May 2018
Published 28 August 2018 Volume 2018:10 Pages 2905—2914
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 2
Editor who approved publication: Dr Antonella D'Anneo
Yan Geng,1,* Jing Liu,2,* Ying Xie,2 Hongmei Jiang,2 Kai Zuo,3 Tao Li,4 Zhiqiang Liu2
1Department of Clinical Laboratory, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, 030012 China; 2Department of Physiology and Pathophysiology, Tianjin Medical University, Heping, Tianjin, 300070 China; 3Department of Infectious Disease, Binzhou People’s Hospital, Binzhou, Shandong, 264000 China; 4Department of Immunology, School of Medicine, Hunan Normal University, Changsha, Hunan, 410013, China
*These authors contributed equally to this work
Background: Histone deacetylase inhibitors are promising drugs for the future application in cancer therapy. Trichostatin A (TSA), a histone deacetylase inhibitor, exhibits effective antitumor effects in various cancers. However, the effects and underlying mechanisms of TSA on multiple myeloma (MM) are not fully investigated.
Methods: In the present study, RPMI8226 and MM.1S cells treated with TSA were used for cell proliferation, cell cycle, and survival examinations, then the localization and post transcriptional modification of GLI1 protein as well as the target gene P21 were analyzed using immunofluorescence, immunoprecipitation, western blots and qPCR, respectively.
Results: TSA exerted a time and dose-dependent cytotoxicity on MM cell lines, and suppressed the proliferation of MM cells and induced an upregulation of p21 protein accompanied by a decreased expression of cyclin D1. TSA treatment led to a downregulation of GLI1, and the nuclear accumulation of GLI1 was also inhibited. As a result of hedgehog inhibition, the expression of MYC and SURVIVIN was greatly weakened after TSA treatment. Furthermore, TSA accelerated GLI1 degradation in a proteasome-dependent manner. Additionally, p21 induction also contributed to GLI1 downregulation via reducing the transcription of GLI in mRNA level. Rescue experiments verified that exogenous expression of GLI1 alleviated MM cell apoptosis induced by TSA.
Conclusion: These results indicated that TSA represses MM cell growth and induces cell apoptosis. The inhibition of hedgehog signaling is an important mechanism accounting for the cytotoxic effects of TSA.
Keywords: histone deacetylase, trichostatin A, multiple myeloma, hedgehog signaling
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]